To view the PDF file, sign up for a MySharenet subscription.

ANHEUSER-BUSCH INBEV SA/NV - Anheuser-Busch InBev reports First Quarter 2017 Results

Release Date: 04/05/2017 07:56
Code(s): ANH     PDF:  
Wrap Text
Anheuser-Busch InBev reports First Quarter 2017 Results

      Anheuser-Busch InBev SA/NV
      (Incorporated in the Kingdom of Belgium)
      Register of Companies Number: 0417.497.106
      Euronext Brussels Share Code: ABI
      Mexican Stock Exchange Share Code: ANB
      NYSE ADS Code: BUD
      JSE Share Code: ANH
      ISIN: BE0974293251
      (“AB InBev” or the “Company”)

      Anheuser-Busch InBev reports First Quarter 2017 Results
      
      The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of
      issuers of financial instruments which have been admitted for trading on a regulated market.
      Except where otherwise stated, the comments below are based on organic growth figures and refer to 1Q17 versus the reference base for the same
      period of last year. For a description of the reference base and important disclaimers please refer to pages 13 and 14.




      HIGHLIGHTS

      -    Revenue: Revenue grew by 3.7% in the quarter, with revenue per hl growth of 4.3%, driven by
           revenue management initiatives as well as strong premium brand performance. On a constant
           geographic basis, revenue per hl grew by 4.5%.
      -    Volume: Total volumes declined by 0.5%, while own beer volumes were down by 0.2%. Good growth
           in own beer volumes was achieved in China, Brazil and Mexico, while declines were recorded in the
           US, Colombia and South Africa.
      -    Global Brands: Combined revenues of our three global brands, Budweiser, Stella Artois and Corona,
           grew by 12.1%. Budweiser revenues grew by 7.3%, with 16.4% growth in revenues outside of the US.
           Stella Artois revenues grew by 21.1%, driven mainly by growth in the US and Argentina. Corona had
           a solid quarter as well, with revenues growing 18.2%, with 48.2% growth in revenues outside of
           Mexico, as a result of strong growth in Western Europe and China.
      -    Cost of Sales (CoS): CoS increased by 5.4% in 1Q17 and by 6.2% on a per hl basis, driven primarily
           by transactional currency and commodity impacts in Latin America North and Latin America South, as
           anticipated. On a constant geographic basis, CoS per hl increased by 6.6%.
          EBITDA: EBITDA grew by 5.8% as a result of top-line growth, aided by cost synergies and other
           operating income, partly offset by the CoS pressure. EBITDA margins expanded by 76 bps to 37.2%.
      -    Net finance results: Net finance costs (excluding non-recurring net finance costs) grew from
           1 219 million USD in 1Q16 to 1 492 million USD in 1Q17, as pre-funding for the SAB combination
           was not in place for the full quarter in the prior year.
      -    Income taxes: Income tax grew from 338 million USD in 1Q16 to 418 million USD in 1Q17 with the
           normalized effective tax rate decreasing from 23.2% to 20.4%.
      -    Profit: Normalized profit attributable to equity holders of AB InBev increased from 844 million USD in
           1Q16 to 1 458 million USD in 1Q17. The 1Q16 profit was impacted by the pre-acquisition funding



ab-inbev.com                                                                                                                                      1
           costs not matched by earnings from SAB and by mark-to-market losses linked to the hedging of
           various share-based payment programs, while the 1Q17 profit benefitted from the earnings of the
           newly combined operations and gains in the mark-to-market adjustments linked to the share-based
           payment programs.
      -    Earnings per share: Normalized earnings per share (EPS) increased from 0.51 USD in 1Q16 to 0.74
           USD in 1Q17, mainly due to higher profit, partially offset by the increased number of shares.
      -    Combination with SAB: The business integration is progressing well, with synergies of 252 million
           USD captured during 1Q17.

      Figure 1. Consolidated performance (million USD)
                                                                                    1Q16                  1Q16           1Q17        Organic
                                                                                Reported        Reference Base                        growth
      Total Volumes (thousand hls)                                               104 868                142 845        147 872          -0.5%
                                                        AB InBev own beer         93 881                117 797        117 729          -0.2%
                                                         Non-beer volumes         10 259                 24 354         29 243          -2.7%
                                                       Third party products           728                   694            900         29.4%
      Revenue                                                                       9 400                12 073         12 922           3.7%
      Gross profit                                                                  5 622                 7 270          7 693           2.6%
      Gross margin                                                                 59.8%                 60.2%          59.5%         -66 bps
      Normalized EBITDA                                                             3 462                 4 490          4 809           5.8%
      Normalized EBITDA margin                                                     36.8%                 37.2%          37.2%          76 bps
      Normalized EBIT                                                               2 693                 3 517          3 721           5.5%
      Normalized EBIT margin                                                       28.6%                 29.1%          28.8%          51 bps

      Profit attributable to equity holders of AB InBev                                 132                              1 405
      Normalized profit attributable to equity holders of AB InBev                      844                              1 458

      Earnings per share (USD)                                                          0.08                              0.71
      Normalized earnings per share (USD)                                               0.51                              0.74



      Figure 2. Volumes (thousand hls)
                                                                     1Q16     Scope            Organic       1Q17    Organic growth
                                                                Reference                       growth                   Total      Own beer
                                                                     Base                                            Volume          volume
      North America                                                 26 913       106            -1 184      25 836      -4.4%          -5.0%
      Latin America West                                            25 672       - 12            - 129      25 531      -0.5%          -1.5%
      Latin America North                                           29 713         27              679      30 419        2.3%           3.8%
      Latin America South                                            8 820          -              270       9 090        3.1%           7.3%
      EMEA                                                          27 965     5 721             - 766      32 919      -2.7%          -1.5%
      Asia Pacific                                                  23 262       - 26              446      23 683        1.9%           1.9%
      Global Export and Holding Companies                              502     - 136                28         395        7.8%           7.8%
      AB InBev Worldwide                                           142 845     5 682             - 655     147 872       -0.5%          -0.2%




      MANAGEMENT COMMENTS

      The first quarter of 2017, which was also the second quarter as a combined company, saw organic
      revenue growth of 3.7%, with volumes down marginally. Global revenue growth was driven by higher
      volumes in Latin America North, Latin America South, and Asia Pacific, and further supported by revenue
      management and premiumization initiatives throughout our markets.

      Organic EBITDA grew by 5.8%, with EBITDA margin expansion of 76 bps, driven by top-line growth and
      the realization of synergies, offsetting an anticipated weak performance in Brazil, where EBITDA was
      down by 23.3%. This was due to the combined impact of a significant cost of sales per hl increase and a
      decline in revenue per hl.

      Excluding Brazil, our business delivered solid results with revenue up 4.2% and EBITDA growing by
      12.3%. We remain optimistic about Brazil in the long run, and more specifically regarding 2017, we will



ab-inbev.com                                                                                                                               2
      soon begin cycling more favorable revenue per hl comparables, while cost of sales per hl growth will
      decelerate to between a flattish and low single-digit increase in the second half of 2017.

      Our global brands continued to show solid growth, with the combined portfolio growing revenue by over
      12%. Budweiser continued to perform well, supported by a powerful Chinese New Year campaign, as well
      as Super Bowl activations introduced for the first time in international markets such as the UK and Brazil.

      Stella Artois grew revenues by more than 20%, with good volume-led performances coming from the US
      and Argentina. This quarter was especially exciting for the brand, as its Buy a Lady a Drink partnership
      with Water.org, which is aimed at ending the global water crisis, was scaled out to 7 markets.

      Corona continued its impressive track record of growth with revenues up by over 18% and by almost 50%
      outside of Mexico, driven primarily by China, the UK and Colombia.

      We will continue fueling the growth of our global brands by leveraging their respective commercial
      platforms with consistent communication and execution around the world, while expanding to new
      markets such as Australia, Peru, Colombia and South Africa.

      The SAB integration continues at a fast pace, with 252 million USD of synergies captured in 1Q17.
      Beyond the cost synergies, we are every day more excited about the top-line growth opportunities arising
      from the combination of these two great companies.

      2017 OUTLOOK

      (i)     Top-line: While recognizing the increased volatility in some of our key markets, we expect to
              accelerate total revenue growth in FY17, driven by the solid growth of our global brands and strong
              commercial plans, including revenue management initiatives.
      (ii)    Cost of Sales: We expect CoS per hl to increase by low single digits on a constant geographic
              basis, despite unfavorable foreign exchange transactional impacts, and growth in our premium
              brands.
      (iii)   Selling, General and Administrative Expenses: We expect SG&A to remain broadly flat, as we
              will continue to find savings in overhead to invest behind our brands.
      (iv)    Synergies: We updated our 2.45 billion USD synergy and cost savings expectation to 2.8 billion
              USD during our FY16 results announcement, with synergies being calculated on a constant
              currency basis as of August 2016.
      (v)     Net Finance Costs: We expect the average rate of interest on net debt in FY17 to be in the range
              of 3.5% to 4.0%. Net pension interest expenses and accretion expenses are expected to be
              approximately 30 and 150 million USD per quarter, respectively. Other financial results will continue
              to be impacted by any gains and losses related to the hedging of our share-based payment
              programs.
      (vi)    Effective Tax Rate: We expect the normalized ETR in FY17 to be in the range of 24% to 26%,
              excluding any potential gains or losses on the hedging of our share-based payment programs. This
              guidance includes the impact of the change in country mix following the combination with SAB and
              the expected tax consequences of the funding of the combination.
      (vii)   Net Capital Expenditure: We expect net capital expenditure of approximately 3.7 billion USD in
              FY17.




ab-inbev.com                                                                                                     3
      (viii) Debt: Approximately one third of AB InBev’s gross debt is denominated in currencies other than the
             US dollar, principally the Euro. Our optimal capital structure remains a net debt to EBITDA ratio of
             around 2x.
      (ix)   Dividends: We continue to expect dividends to be a growing flow over time, although growth is
             expected to be modest given the importance of deleveraging.




      BUSINESS REVIEW

      United States

      We estimate that industry STRs in the United States declined by 1.6% in 1Q17, cycling growth in 1Q16
      that had the benefit of an early Easter. Our own STRs were down 2.9%, leading to an estimated decline
      in total market share of approximately 60 bps. Our STWs were down 4.7% in the quarter, due to planned
      adjustments to wholesaler inventories in the normal course of business. We continue to expect our STRs
      and STWs to converge over time.

      Market share trends are in line with the past two quarters, with softer performance in our Premium Light
      and Premium Regular segments offset by continued growth in Above Premium.

      Bud Light volume trends in the quarter were mixed, with positive share trends in some states not enough
      to reverse the negative trends in our largest markets. A new Bud Light campaign, entitled “Famous
      Among Friends”, was launched in the first quarter and aired during the Super Bowl, bringing the brand
      back to its roots. Bud Light STRs declined by mid-single digits in the quarter, with an estimated total
      market share loss of approximately 65 bps.

      Budweiser volumes were also down mid-single digits with market share loss of approximately 35 bps.
      However, the brand has established a strong platform, which reinforces the brand’s quality credentials
      and proud American heritage.

      Our portfolio of Above Premium brands continued to perform well, gaining approximately 30 bps of total
      market share in the quarter. Michelob Ultra, with its “Active Lifestyle” positioning, was the top share gainer
      in the US for the eighth consecutive quarter and is now the market leader in the Above Premium segment
      by volume, according to IRI. Our other Above Premium brands also performed well, led by Stella Artois
      and our regional craft portfolio.

      Our value brands performed well within the quarter, leveraged by the Busch Super Bowl ad. These
      brands have retained many loyal consumers and continue to play an important role in our portfolio.

      We are working more closely than ever with our wholesalers, as part of our “Winning Together” platform.
      We made good strides in 2016, and in 2017 we will continue to build on this success with a focus on
      increasing our engagement and furthering collaboration with our wholesaler partners.

      US beer revenue per hl grew by 2.2%, driven by strong price discipline and a positive brand mix. With
      volumes down 4.7%, revenue for the quarter declined by 2.6%. However, we continued to achieve margin



ab-inbev.com                                                                                                      4
      expansion, with gross margin up by 68 bps to 60.6% and organic EBITDA margin up 41 bps to 40.2%,
      despite a 1.6% decline in EBITDA.


      Mexico

      Our business in Mexico continued to perform well, with volumes growing by low single digits and
      revenues growing by high single digits, despite cycling a tough comparable as a result of the timing of
      Easter. These results were driven by healthy performances from our brands, with double-digit growth in
      the Victoria brand and mid-single digit growth in the Modelo family, combined with excellent results from
      our global and international brands. Revenue per hl growth of 4% was achieved in an environment of
      macroeconomic uncertainty and volatile exchange rates, especially following the January increase in oil
      prices, which put pressure on consumer confidence.

      EBITDA in Mexico grew by 17.1%, representing an EBITDA margin expansion of over 300 bps to 42.1%,
      as a result of the strong top-line performance coupled with favorable currency and commodity hedges
      and an increase in other operating income.


      Colombia

      Our Colombian volumes declined by 7.9%, with total revenues declining by 5.1%. This was largely due to
      a country-wide VAT increase at the start of the year which put pressure on consumers, as well as a tough
      comparable due to the timing of Easter. Despite the soft top-line result, we gained an estimated 10 bps of
      share of total alcohol while implementing our high end strategy to drive growth of our global brands.

      Colombia EBITDA declined by 10.1%, with margin contraction of 266 bps to 47.7%. While this
      performance was partly due to the lower top-line result, it was exacerbated by: i) the phasing of SG&A
      initiatives, ii) the reversal of certain provisions in 1Q16 positively impacting the country’s performance in
      prior year, and iii) the impact of several costs previously recorded in Peru, Ecuador and the former SAB’s
      “Latin America hub” in Miami now recorded in Colombia, which became the Zone headquarters.


      Brazil

      Our Brazil business saw beer volumes growing by 3.4% in the quarter. The political and macroeconomic
      environment in Brazil remains challenging and we estimate beer industry volumes declined this quarter.
      In our non-beer business, volumes were roughly flat in an industry that we also estimate has declined.

      Revenue per hl decreased by 1.8% due to a tough comparable, as large state tax increases during the
      course of 2016 have yet to be fully passed on to consumers. Additionally, we saw continued growth of our
      returnable glass bottles, which have a negative impact on revenue per hl but are accretive for both
      EBITDA and margin. The negative revenue per hl result was partially offset by the continued growth of
      our premium brands, with Budweiser volumes growing by more than 30%.

      Cost of sales per hl was affected, as anticipated, by a USDBRL devaluation of close to 40%, embedded
      in our CoS. Currently, approximately half of our CoS in Brazil is denominated in USD. CoS per hl is
      expected to grow double-digits in the first half, and to be flattish to up low single digits in the second half
      of 2017. The combined impact of a significant CoS per hl increase, which explains more than 75% of our
      EBITDA decline, and the decline in revenue per hl, led to a 23.3% reduction in EBITDA, with EBITDA
      margin contraction of approximately 1200 bps to 38.8%.




ab-inbev.com                                                                                                       5
      South Africa

      Our South African business saw strong revenue growth of mid-single digits, driven by significant pricing
      in the period prior to change of control. Beer volumes declined by 1.6%, impacted by the timing of Easter.
      Synergy capture, combined with good cost management and an increase in other operating income, led
      to EBITDA growth in the high teens and approximately 500 bps of EBITDA margin expansion.

      Castle Lite continues its strong growth in the core plus segment with packaging innovations aimed at
      improving convenience for in-home consumption. Core brands recovered some of the prior year volume
      losses to cheap wines and spirits through our commercial initiatives.

      The business is well-positioned to grow our global brands, with Stella Artois and Corona already present
      in the market and plans to launch Budweiser later in the year.


      China


      Our business in China had a great start to the year, posting revenue growth over 11%. This was driven
      by a 5% increase in volumes and a 6% increase in revenue per hl through a combination of revenue
      management initiatives, innovation and brand mix benefitting from superior growth in the premium and
      super premium brands.

      Chinese New Year at the end of January offered excellent opportunities to connect and celebrate with
      consumers in the year of the rooster, both on- and off-line, especially for Budweiser and Harbin Ice, which
      both recorded double-digit growth. The occasion-focused expansion strategy of Budweiser is helping the
      brand to gain momentum in key regions.

      Market share rose above 20% in an industry that showed a modest recovery after cycling industry
      declines of 4% in the prior year. We saw organic growth in EBITDA of 39.6% with a 681 bps increase in
      EBITDA margin, driven by top-line growth as well as efficiencies, productivity gains and footprint
      optimization, assisted by lower raw material prices.

      We continue to believe that our brand portfolio, which over-indexes in the faster-growing premium and
      super premium segments, is well-positioned to continue growing ahead of the industry.


      Highlights from our other markets

      Canada reported solid financial performance in 1Q17, growing topline despite a softer industry, with a
      decline in volume more than offset by strong revenue per hl performance and continued cost discipline to
      deliver growth in both revenue and EBITDA. While the total share declined marginally, we saw improved
      trends in Budweiser, which is the country’s biggest brand, continued share gains in Bud Light, and a
      strong performance from our craft portfolio and ready-to-drink brands.

      Peru recorded almost 3% growth in revenue on flattish volumes, although major flooding in the country
      resulted in infrastructure damage that isolated many regions in the North. Ecuador recorded double-digit
      declines in beer volumes, as the economy continues to struggle to recover from a recession exacerbated
      by the earthquake in April 2016.

      In Latin America South, strong beer volume growth was recorded in Argentina, Chile, Bolivia, Uruguay
      and Paraguay despite negative growth in soft drinks. Argentina saw volumes return to growth, up high



ab-inbev.com                                                                                                   6
      single digits, as a result of our commercial plans as well as a more benign macroeconomic environment.
      Our global brands performed especially well in the region, with volumes and revenues up by double-
      digits.

      Within EMEA, Western Europe grew revenue by mid-single digits, underpinned by market share gains in
      the majority of our markets and double-digit growth in the UK assisted by the launch of Bud Light. In
      Eastern Europe, revenue contraction was driven by the continued decline of volumes, which was
      accentuated by the introduction of a ban on PET pack sizes larger than 1.5 liters in Russia. In Africa,
      double-digit beer volume and revenue growth was recorded in both Nigeria and Uganda. However, in
      Mozambique, volumes declined by low single digits in response to revenue management initiatives
      undertaken as a result of devaluation-led inflation. Tanzania and Zambia were both negatively impacted
      by macroeconomic conditions and their non-beer businesses.

      Australia continues to gain share and achieved 6.6% revenue growth this quarter. This result was driven
      by a price-mix improvement as well as doubling of revenue from the Great Northern brand, combined with
      excellent growth in the repositioned Pure Blonde. The business is positioned to leverage the reclaimed
      global brand portfolio, which is already well-established with Corona having over 5% market share.

        CONSOLIDATED INCOME STATEMENT

      Figure 3. Consolidated income statement (million USD)
                                                                 1Q16                1Q16    1Q17      Organic
                                                              Reported     Reference Base               growth
      Revenue                                                     9 400            12 073   12 922       3.7%
      Cost of sales                                              -3 778            -4 803   -5 229      -5.4%
      Gross profit                                                5 622             7 270    7 693       2.6%
      SG&A                                                       -3 092            -3 960   -4 228      -1.7%
      Other operating income/(expenses)                             163               208      257      40.6%
      Normalized profit from operations
      (normalized EBIT)                                           2 693             3 517    3 721        5.5%
      Non-recurring items above EBIT                                - 34                     - 221
      Net finance income/(cost)                                  -1 219                     -1 492
      Non-recurring net finance income/(cost)                     - 684                         99
      Share of results of associates                                   1                        54
      Income tax expense                                          - 338                      - 418
      Profit from continuing operations                             419                      1 743
      Discontinued operations results                                  -                        28
      Profit                                                        419                      1 771
      Profit attributable to non-controlling interest               287                        366
      Profit attributable to equity holders of AB InBev             132                      1 405

      Normalized EBITDA                                          3 462              4 490    4 809        5.8%
      Normalized profit attributable to equity
      holders of AB InBev                                          844                       1 458


      Revenue
      Consolidated revenue grew by 3.7% in 1Q17, with revenue per hl growth of 4.3%. This result was driven
      by our revenue management and premiumization initiatives. On a constant geographic basis revenue per
      hl grew by 4.5%.

      Cost of Sales (CoS)
      Total CoS increased by 5.4%, and by 6.2% on a per hl basis. This increase was driven primarily by
      anticipated transactional foreign exchange and commodity impacts, which were partly offset by synergy
      capture, procurement savings and efficiencies. On a constant geographic basis, CoS per hl increased by
      6.6%.

      Selling General and Administrative Costs (SG&A)
      SG&A grew by 1.7%, which was well below inflation, reflecting synergy capture combined with good cost
      control.


ab-inbev.com                                                                                                7
      Other operating income
      Other operating income increased organically by 40.6% as a result of reduction of operating costs mainly
      in Africa and government incentives in China.




      Non-recurring items above EBIT

       Figure 4. Non-recurring items above EBIT (million USD)
                                                                                                  1Q16      1Q17
       Restructuring                                                                                -20      -189
       Acquisition costs / Business combinations                                                    -18       -17
       Business and asset disposal (including impairment losses)                                      4       -15
       Impact on profit from operations                                                             -34      -221


      Normalized profit from operations excludes negative non-recurring items of 221 million USD, primarily
      related to the one-off restructuring costs related to the SAB integration.

       Figure 5. Net finance income/(cost) (million USD)
                                                                                                  1Q16      1Q17
       Net interest expense                                                                       - 681    -1 084
       Net interest on net defined benefit liabilities                                              - 29      - 29
       Accretion expense                                                                          - 143     - 169
       Other financial results                                                                    - 366     - 210
       Net finance income/(cost)                                                                 -1 219    -1 492

      Net finance costs (excluding non-recurring net finance costs) were 1 492 million USD in 1Q17 compared
      to 1 219 million USD in 1Q16. Net interest expense increased from 681 million USD to 1 084 million USD,
      now reflecting the full quarterly interest costs associated with the bonds issued throughout 2016. Other
      financial results include a mark-to-market gain of 130 million USD in 1Q17, linked to the hedging of our
      share-based payment programs, compared to a loss of 138 million USD in 1Q16.

      The number of shares covered by the hedging of our share-based payment programs, and the opening
      and closing share prices, are shown in figure 6 below.

       Figure 6. Share-based payment hedge
                                                                                                  1Q16      1Q17
       Share price at the start of the period (Euro)                                             114.40    100.55
       Share price at the end of the period (Euro)                                               109.25    102.90
       Number of equity derivative instruments at the end of the period (millions)                 37.7      48.5

      Non-recurring net finance income/(cost)

       Figure 7. Non-recurring net finance income/(cost) (million USD)
                                                                                                  1Q16      1Q17
       Mark-to-market (Grupo Modelo deferred share instrument)                                      -84       54
       Mark-to-market (Portion of the FX hedging of the purchase price of the combination with
                                                                                                  - 599          -
       SABMiller that did not qualify for hedge accounting)
       Other mark-to-market                                                                         125        45
       Other                                                                                       -126         -
       Non-recurring net finance income/(cost)                                                     -684        99




ab-inbev.com                                                                                                    8
      Non-recurring net finance income was 99 million USD in 1Q17 compared to a cost of 684 million USD
      in 1Q16. Non-recurring net finance costs in 1Q16 included a negative mark-to-market adjustment of 599
      million USD, related to the portion of the FX hedging of the purchase price of the combination with SAB
      that did not qualify for hedge accounting under IFRS rules.
      The 1Q17 result includes a positive mark-to-market adjustment on our non-recurring equity derivative
      instruments relating to the issue of deferred shares in the Grupo Modelo combination and the issue of
      restricted shares in the SAB combination. The number of shares covered by the hedging of the deferred
      share instrument and the restricted shares are shown in figure 8, together with the opening and closing
      share prices.

       Figure 8. Non-recurring equity derivative instruments
                                                                                                       1Q16     1Q17
       Share price at the start of the period (Euro)                                                  114.40   100.55
       Share price at the end of the period (Euro)                                                    109.25   102.90
       Number of equity derivative instruments at the end of the period (millions)                      23.1     43.9

      Income tax expense

       Figure 9. Income tax expense (million USD)
                                                                                                       1Q16     1Q17
       Income tax expense                                                                                338     418
       Effective tax rate                                                                             44.7%    19.8%
       Normalized effective tax rate                                                                  23.2%    20.4%

      Income tax expense in 1Q17 was 418 million USD with a normalized effective tax rate (ETR) of 20.4%,
      compared to an income tax expense of 338 million USD in 1Q16 and a normalized ETR of 23.2%. The
      decrease in normalized ETR in 1Q17 is mainly due to country mix and the reporting of the SAB results
      following the combination, matching the acquisition funding.

      The decrease in the reported ETR from 44.7% in 1Q16 to 19.8% in 1Q17 is mainly due to the 2016 non-
      deductible negative mark-to-market related to the hedging of the purchase price of SAB that did not
      qualify for hedge accounting.

      Profit attributable to non-controlling interest
      Profit attributable to non-controlling interest increased from 287 million USD in 1Q16 to
      366 million USD in 1Q17, mainly as a result of the combination with SAB.

      Normalized Profit and Profit

       Figure 10. Normalized profit attribution to equity holders of AB InBev (million USD)
                                                                                                       1Q16     1Q17
       Profit attributable to equity holders of AB InBev                                                132     1 405
       Non-recurring items, after taxes, attributable to equity holders of AB InBev                      28       180
       Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev     684       - 99
       Discontinued operations results                                                                    -       - 28
       Normalized profit attributable to equity holders of AB InBev                                     844     1 458

      Normalized profit attributable to equity holders of AB InBev increased from 844 million USD in 1Q16 to
      1 458 million USD in 1Q17
      Profit attributable to equity holders of AB InBev increased from 132 million USD in 1Q16 to 1 405 million
      USD in 1Q17.

      Normalized and Basic EPS



ab-inbev.com                                                                                                        9
       Figure 11. Earnings per share (USD)
                                                                                                                1Q16                   1Q17
       Basic earnings per share                                                                                  0.08                   0.71
       Non-recurring items, after taxes, attributable to equity holder of AB InBev, per share                    0.01                   0.09
       Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev,
       per share                                                                                                 0.42                  -0.05
       Discontinued operations results, per share                                                                   -                  -0.01
       Normalized earnings per share                                                                             0.51                   0.74

      Normalized earnings per share (EPS) increased from 0.51 USD in 1Q16 to 0.74 USD in 1Q17.

       Figure 12. Key components - Normalized earnings per share in USD
                                                                                                                1Q16                   1Q17
       Normalized EBIT                                                                                           1.64                   2.27
       Mark-to-market (Hedging of our share-based payment programs)                                             -0.08                   0.08
       Pre-funding of SAB transaction                                                                           -0.20                      -
       Net finance cost                                                                                         -0.46                  -0.99
       Income tax expense                                                                                       -0.21                  -0.28
       Associates & non-controlling interest                                                                    -0.18                  -0.19
       Share dilution                                                                                               -                  -0.15
       Normalized EPS                                                                                            0.51                   0.74


       Note: 1Q16 and 1Q17 before dilution calculated based upon weighted average number of shares per 1Q16 of 1 641 million shares.
       EPS after dilution based upon weighted average number of shares per 1Q17 of 1 970 million shares.


      Reconciliation between profit attributable to equity holders and normalized EBITDA

       Figure 13. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD)
                                                                                                               1Q16                    1Q17
                                                                                                          Reported
       Profit attributable to equity holders of AB InBev                                                          132                  1 405
       Non-controlling interests                                                                                  287                    366
       Profit                                                                                                     419                  1 771
       Discontinued operations results                                                                              -                    - 28
       Profit from continuing operations                                                                          419                  1 743
       Income tax expense                                                                                         338                    418
       Share of result of associates                                                                               -1                    - 54
       Net finance (income)/cost                                                                               1 219                   1 492
       Non-recurring net finance (income)/cost                                                                    684                    - 99
       Non-recurring items above EBIT (incl. non-recurring impairment)                                             34                    221
       Normalized EBIT                                                                                         2 693                   3 721
       Depreciation, amortization and impairment                                                                  769                  1 088
       Normalized EBITDA                                                                                       3 462                   4 809

      Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the
      company’s underlying performance.

      Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders
      of AB InBev: (i) non-controlling interest; (ii) discontinued operations results; (iii) income tax expense; (iv)
      share of results of associates; (v) net finance cost; (vi) non-recurring net finance cost; (vii) non-recurring
      items above EBIT (including non-recurring impairment); and (viii) depreciation, amortization and
      impairment.




ab-inbev.com                                                                                                                              10
      Normalized EBITDA and normalized EBIT are not accounting measures under IFRS accounting and
      should not be considered as an alternative to profit attributable to equity holders as a measure of
      operational performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and
      normalized EBIT do not have a standard calculation method and AB InBev’s definition of normalized
      EBITDA and normalized EBIT may not be comparable to that of other companies.




      RECENT EVENTS

      1. Exchange of High Coupon Bonds

        On 22 March 2017, AB InBev announced the commencement of ten separate private offers to certain
        eligible bondholders (the “Exchange Offers”) to exchange any and all of the outstanding notes listed
        below (the “Existing Notes”) issued by either Anheuser-Busch Companies, LLC (“ABC”) or Anheuser-
        Busch InBev Worldwide Inc. (“ABIWW”) for a combination of ABIWW’s new notes (the “New Notes”)
        and cash. The notes targeted had a total principal amount outstanding of 3.1 billion USD and on
        average carried a coupon of approximately 6.4% per annum.

        On 18 April 2017, the Exchange Offers expired and approximately 44% of the aggregate principal
        amount of the Existing Notes were tendered. In exchange for the Existing Notes, ABIWW issued
        approximately 1,735 million USD of New Notes that mature on October 6, 2048 and will bear interest at
        a rate per annum of 4.439%. The Exchange Offers were intended to simplify AB InBev’s capital
        structure, extend the maturity dates of AB InBev’s debt, reduce AB InBev’s interest expenses by retiring
        high-coupon debt during a time of favorable market conditions and better align the restrictive covenants
        in AB InBev’s debt across its capital structure.

                                                       Original Principal         Principal Amount Outstanding
          Title of Security            Issuer         Amount Outstanding                 After Exchange


    7.55% Debentures due 2030           ABC               $200,000,000                     $125,954,000

    6.80% Debentures due 2031           ABC               $200,000,000                     $180,014,000

    6.80% Debentures due 2032           ABC               $300,000,000                     $173,068,000

    5.95% Debentures due 2033           ABC               $300,000,000                     $151,817,000

    5.75% Debentures due 2036           ABC               $300,000,000                     $107,314,000

    6.450% Debentures due 2037          ABC               $500,000,000                     $247,444,000

    6.375% Notes due 2040              ABIWW              $500,000,000                     $244,425,000

    6% Debentures due 2041              ABC               $250,000,000                     $166,417,000

    6.50% Debentures due 2042           ABC               $250,000,000                     $175,551,000



ab-inbev.com                                                                                                 11
    6.50% Debentures due 2043                    ABC                   $300,000,000                             $177,608,000


      2. Partial Repayment of 8 billion USD Term Loan due 2021

        On 10 April 2017, we repaid 6 billion USD of the 8 billion USD Term Loan due 2021, leaving 2 billion
        USD outstanding. This Term Loan is the last remaining facility of the 75 billion USD credit facilities
        raised in October 2015 to finance the combination with SAB. The repayment is an important step in our
        long-term deleveraging commitment.

      3. Disposal of Interest in Distell Group Limited to the Public Investment Corporation

        On 12 April 2017, we announced completion of the sale of our entire indirect shareholding in Distell
        Group Limited to the Public Investment Corporation (SOC) Limited, acting on behalf of the Government
        Employees Pension Fund. The sale was required as a condition of the South African Competition
        Tribunal’s approval on 30 June 2016 of our business combination with SAB.


      NOTES
      To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press
      release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed
      eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Scope changes represent
      the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments,
      curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does
      not consider as part of the underlying performance of the business.

      All references per hectoliter (per hl) exclude US non-beer activities. To eliminate the effect of geography mix, i.e. the impact of
      stronger volume growth coming from countries with lower revenue per hl, and lower Cost of Sales per hl, we are also presenting,
      where specified, organic growth per hectoliter figures on a constant geographic basis. When we make estimations on a constant
      geographic basis, we assume each country in which we operate accounts for the same percentage of our global volume as in the
      same period of the previous year.

      Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a
      “normalized” basis, which means they are presented before non-recurring items and discontinued operations. Non-recurring items
      are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented
      separately because they are important for the understanding of the underlying sustainable performance of the Company due to their
      size or nature. Normalized measures are additional measures used by management, and should not replace the measures
      determined in accordance with IFRS as an indicator of the Company’s performance. The results of the CEE business are presented
      as “discontinued operations result” until their disposal on 31 March 2017. Values in the figures and annexes may not add up, due to
      rounding.

      Given the transformational nature of the transaction with SAB that closed on 10 October 2016, and to facilitate the understanding of
      AB InBev’s underlying performance, AB InBev has updated its 1Q16 segment reporting for purposes of this results announcement
      and internal review by senior management. This presentation (referred to as the “Reference Base”) includes, for comparative
      purposes, the results of the SAB business as if the combination had taken place at the beginning of 4Q15, but excluding the results
      of (i) those business sold since the combination was completed, including the joint venture stakes in MillerCoors and CR Snow, and
      the sale of the Peroni, Grolsch and Meantime brands and associated businesses in Italy, the Netherlands, the UK and internationally
      and (ii) the Central and Eastern Europe business and the stake in Distell. The changes, effective 1 October 2016, include the former
      SAB geographies. Colombia, Peru, Ecuador, Honduras and El Salvador are reported together with Mexico as Latin America West,
      Panama is reported within Latin America North, Africa is reported together with Europe as EMEA, and Australia, India and Vietnam
      are reported within APAC.

      1Q17 EPS is based upon a weighted average of 1,970 million shares for 1Q17 compared to a weighted average of 1,641 million
      shares for 1Q16.


      Legal Disclaimer
      This release contains “forward-looking statements”. These statements are based on the current expectations and views of future
      events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances.



ab-inbev.com                                                                                                                          12
      The forward-looking statements contained in this release include, among other things, statements relating to AB InBev’s business
      combination with SAB and other statements other than historical facts. Forward-looking statements include statements typically
      containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “estimates”, “likely”,
      “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You
      should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB
      InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are
      outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to
      be materially different, including the ability to realize synergies from the business combination with SAB, the risks and uncertainties
      relating to AB InBev described under Item 3.D of AB InBev’s Annual Report on Form 20-F (“Form 20-F”) filed with the US Securities
      and Exchange Commission (“SEC”) on 22 March 2017. Other unknown or unpredictable factors could cause actual results to differ
      materially from those in the forward-looking statements.

      The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere,
      including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev or
      SAB have made public. Any forward-looking statements made in this communication are qualified in their entirety by these
      cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be
      realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business
      or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking
      statements, whether as a result of new information, future events or otherwise.

      The 2016 Reference Base information is based in part on certain assumptions that AB InBev believes are reasonable under the
      circumstances. The 2016 Reference Base information is presented for illustrative purposes only and does not necessarily reflect
      the results of operations or the financial position of the combined former AB InBev and SAB groups that would have resulted had the
      combination occurred on 8 October 2015, or project the results of operations or financial position of the combined group for any
      future date or period. The 2016 Reference Base information is not pro forma financial information, and has not been prepared in
      accordance with Article 11 of Regulation S-X promulgated by the U.S. Securities and Exchange Commission. It is therefore not
      consistent in terms of content and presentation with pro forma financial information that would be included in reports filed under
      Sections 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934, as amended.



      NOTES

      The first quarter 2017 (1Q17) financial data set out in Figure 1 (except for the volume information), Figures 3 to 5, 7, 9 to 11 and 13
      of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and
      for the three months ended 31 March 2017, which have been reviewed by our statutory auditors Deloitte Bedrijfsrevisoren BCVBA in
      accordance with the standards of the Public Company Accounting Oversight Board (United States). The auditors concluded that,
      based on their review, nothing had come to their attention that caused them to believe that those interim financial statements were
      not presented fairly, in all material respects, in accordance with IAS 34 “Interim Financial Reporting”, as issued by the IASB and as
      adopted by the European Union. Financial data included in Figures 6, 8 and 12 have been extracted from the underlying accounting
      records as of and for the three months ended 31 March 2017 (except for the volume information).



      CONFERENCE CALL AND WEBCAST

      Investor Conference call and Webcast on Wednesday, 4 May 2017:

      3.00pm Brussels / 2.00pm London / 9.00am New York

      Registration details

      Webcast (listen-only mode)
      http://bit.ly/webcastq1

      Conference call (with interactive Q&A)
      http://www.directeventreg.com/registration/event/11944116




ab-inbev.com                                                                                                                             13
      ANHEUSER-BUSCH INBEV CONTACTS

      Media                                                                               Investors
      Marianne Amssoms                                                                    Henry Rudd
      Tel: +1-212-573-9281                                                                Tel: +1-212-503-2890
      E-mail: marianne.amssoms@ab-inbev.com                                               E-mail: henry.rudd@ab-inbev.com

      Kathleen Van Boxelaer                                                               Mariusz Jamka
      Tel: +32-16-27-68-23                                                                Tel: +32-16-27-68-88
      E-mail: kathleen.vanboxelaer@ab-inbev.com                                           E-mail: mariusz.jamka@ab-inbev.com

                                                                                          Lauren Abbott
                                                                                          Tel: +1-212-573-9287
                                                                                          E-mail: lauren.abbott@ab-inbev.com



      4 May 2017
      Sponsor: Deutsche Securities SA Proprietary Limited


      About Anheuser-Busch InBev

      Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the
      Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York
      Stock Exchange (NYSE: BUD). Our Dream is to bring people together for a better world. Beer, the original social network, has been
      bringing people together for thousands of years. We are committed to building great brands that stand the test of time and to
      brewing the best beers using the finest natural ingredients. Our diverse portfolio of well over 500 beer brands includes global brands
      Budweiser®, Corona® and Stella Artois®; multi-country brands Beck’s®, Castle®, Castle Lite®, Hoegaarden® and Leffe®; and
      local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Chernigivske®, Cristal®, Harbin®, Jupiler®,
      Klinskoye®, Michelob Ultra®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, Sibirskaya Korona® and Skol®. Our brewing
      heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn
      brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle
      Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with
      a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 200,000
      employees based in more than 50 countries worldwide. For 2016, AB InBev’s reported revenue was 45.5 billion USD (excluding JVs
      and associates).




ab-inbev.com                                                                                                                            14
      Annex 1
      AB InBev Worldwide                                      1Q16    Scope       Currency     Organic       1Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                          142 845    5 682               -      - 655    147 872      -0.5%
                       of which AB InBev own beer           117 797      138               -      - 206    117 729      -0.2%
      Revenue                                                12 073      109            304         436     12 922       3.7%
      Cost of sales                                          -4 803      - 48         - 128       - 250     -5 229      -5.4%
      Gross profit                                            7 270        61           176         186      7 693       2.6%
      SG&A                                                   -3 960    - 104            - 97        - 67    -4 228      -1.7%
      Other operating income/(expenses)                         208      - 35             14          70       257     40.6%
      Normalized EBIT                                         3 517      - 77             93        188      3 721       5.5%
      Normalized EBITDA                                       4 490      - 46           109         256      4 809       5.8%
      Normalized EBITDA margin                               37.2%                                          37.2%      76 bps

      North America                                           1Q16    Scope       Currency     Organic       1Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           26 913     106               -      -1 184     25 836      -4.4%
      Revenue                                                 3 532       41             15         -74      3 514       -2.1%
      Cost of sales                                          -1 358     - 27             -3           51    -1 337       3.8%
      Gross profit                                            2 175       14             11         - 23     2 177       -1.0%
      SG&A                                                    - 992     - 18             -7           -3    -1 019      -0.3%
      Other operating income/(expenses)                          11        -              -            4        15     32.3%
      Normalized EBIT                                         1 194       -3              5         - 22     1 173      -1.9%
      Normalized EBITDA                                       1 384       -1              5         - 17     1 371       -1.2%
      Normalized EBITDA margin                               39.2%                                          39.0%      34 bps

      Latin America West                                      1Q16    Scope       Currency     Organic       1Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           25 672     - 12               -      - 129     25 531     -0.5%
      Revenue                                                 1 974       -1            - 57          60     1 976      3.0%
      Cost of sales                                           - 576        1              22        - 32     - 585     -5.5%
      Gross profit                                            1 398        -            - 35          28     1 391      2.0%
      SG&A                                                    - 676     - 11              23          17     - 647      2.5%
      Other operating income/(expenses)                          38     - 34              -2          23        25         -
      Normalized EBIT                                           760     - 45            - 14          68       769      9.5%
      Normalized EBITDA                                         915     - 45            - 20          70       921      8.1%
      Normalized EBITDA margin                               46.4%                                          46.6%    216 bps

      Latin America North                                     1Q16    Scope       Currency     Organic       1Q17    Organic
                                                    Reference Base              translation     growth                growth
      Total volumes (thousand hls)                           29 713      27               -         679     30 419        2.3%
      Revenue                                                 1 900       -             397           38     2 335        2.0%
      Cost of sales                                           - 652       -           - 169       - 177      - 997     -27.1%
      Gross profit                                            1 248       -             228       - 139      1 337      -11.1%
      SG&A                                                    - 586      -7           - 127         - 13     - 733       -2.2%
      Other operating income/(expenses)                         100      -2              18         - 25        91     -25.1%
      Normalized EBIT                                           763      -9             119       - 177        696     -23.5%
      Normalized EBITDA                                         931      -9             154       - 175        901      -19.0%
      Normalized EBITDA margin                               49.0%                                          38.6%    -996 bps




ab-inbev.com                                                                                                              15
      Annex 1
      Latin America South                                     1Q16    Scope       Currency      Organic      1Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                            8 820         -              -         270     9 090        3.1%
      Revenue                                                   727         -           - 53         199       872       27.4%
      Cost of sales                                           - 229         -             14       - 101     - 315      -44.2%
      Gross profit                                              498         -           - 39           98      557       19.6%
      SG&A                                                    - 174         -             14         - 48    - 208      -27.7%
      Other operating income/(expenses)                           2         -               -          -1        1      -74.9%
      Normalized EBIT                                           326         -           - 25           48      349       14.8%
      Normalized EBITDA                                         366         -           - 28           60      399       16.4%
      Normalized EBITDA margin                               50.4%                                          45.7%     -433 bps

      EMEA                                                    1Q16    Scope       Currency      Organic      1Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                           27 965    5 721               -       - 766    32 919      -2.7%
                       of which AB InBev own beer            18 853      208               -       - 277    18 784      -1.5%
      Revenue                                                 1 885      328              35           93    2 341       4.9%
      Cost of sales                                           - 877    - 234            - 16            1   -1 126       0.1%
      Gross profit                                            1 007        95             18           94    1 215       9.3%
      SG&A                                                    - 643      - 82           - 15         - 39    - 779      -6.1%
      Other operating income/(expenses)                          -7         1              2           31       26          -
      Normalized EBIT                                           357        14              5           86      462      24.0%
      Normalized EBITDA                                         521        41              5           97      664      18.6%
      Normalized EBITDA margin                               27.7%                                          28.4%     358 bps

      Asia Pacific                                            1Q16    Scope       Currency      Organic      1Q17     Organic
                                                    Reference Base              translation      growth                growth
      Total volumes (thousand hls)                           23 262     - 26               -        446     23 683       1.9%
      Revenue                                                 1 699        -            - 33        135      1 801       8.0%
      Cost of sales                                           - 826        2              22          -5     - 806      -0.6%
      Gross profit                                              873        2            - 11        130        995      14.9%
      SG&A                                                    - 572       -7              14        - 35     - 600      -6.0%
      Other operating income/(expenses)                          32        -              -2          12        42      37.5%
      Normalized EBIT                                           334       -5               1        107        437      32.6%
      Normalized EBITDA                                         533       -4              -8        133        654      25.2%
      Normalized EBITDA margin                               31.4%                                          36.3%     497 bps

      Global Export and Holding                               1Q16    Scope       Currency      Organic      1Q17     Organic
      Companies                                     Reference Base              translation      growth                growth
      Total volumes (thousand hls)                              502    - 136              -           28       395        7.8%
      Revenue                                                   357    - 259              -         - 14         83     -14.5%
      Cost of sales                                           - 287      209              3           12       - 63      15.2%
      Gross profit                                               70      - 50             3           -2         21     -11.7%
      SG&A                                                    - 319        23             1           54     - 242       18.1%
      Other operating income/(expenses)                          32         -            -2           27         57      83.9%
      Normalized EBIT                                         - 218      - 27             2           78     - 165       32.0%
      Normalized EBITDA                                       - 161      - 27             1           87     - 100       46.5%




ab-inbev.com                                                                                                               16

Date: 04/05/2017 07:56:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story